Stay updated on Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial
Sign up to get notified when there's something new on the Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial page.

Latest updates to the Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added and the government funding lapse notice along with Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding lapse and NIH Clinical Center status, with links to cc.nih.gov and opm.gov. Updated the page revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.3%

- Check28 days agoChange DetectedShow glossary added; Last Update Submitted that Met QC Criteria label added; No FEAR Act Data text added; Revision: v3.4.0 shown, replacing v3.3.4 references. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page shows a minor site revision update: an addition of Revision: v3.3.4 and a removal of Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded Locations section with Gyeonggi-do; removed the separate 'Gyeonggi-do Locations' heading and updated to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedTwo editorial updates were made: the Publications note wording changed slightly, and the page revision tag was updated from v3.2.0 to v3.3.2. These are minor updates and do not affect study data or results.SummaryDifference0.1%

Stay in the know with updates to Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial page.